Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Oryx Horn General Information
Oryx Horn is a private investment firm providing growth capital to healthcare service businesses with $1–5 million EBITDA. The firm specializes in supporting management teams and founders to accelerate business growth through operational expertise in physician-constrained specialties. It does not develop drugs or own clinical-stage assets but focuses on scaling healthcare operations post-acquisition.
Contact Information
Drug Pipeline
No pipeline data available
Key Partnerships
Recruiting partnerships for business analysis and physician support; no major pharma/biotech partnerships disclosed.
Oryx Horn Funding
No funding data available
To view Oryx Horn's complete valuation and funding history, request access »